Microchimerism has been defined by the presence of a low number of circulating cells transferred from one individual to another. This transfer takes place naturally during pregnancy, between mother and fetus, or between fetuses in multigestational pregnancies. Furthermore, the establishment of microchimerism can also occur during blood transfusion, as well as during bone marrow and solid-organ transplants. Recently, microchimeric cells have been implicated in the pathogenesis of autoimmune diseases, particularly systemic sclerosis. Studies have demonstrated an increased presence of microchimeric cells in peripheral blood and tissues from patients with systemic sclerosis, and, more recently, microchimeric cells were demonstrated to be specifically activated and capable of recognizing patient human leukocyte antigens.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Eng J Med 1998, 338:1186–1191. This paper is a seminal publication that demonstrates, for the first time, the presence of fetal microchimeric cells in the active lesions of patients with SSc, and also that microchimeric cells in the peripheral blood are CD3+ T cells.CrossRefGoogle Scholar
- 2.Artlett CM, Cox LA, Ramos RC, et al.: Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol 2002, 103:303–308. This paper identifies the presence of fetal microchimeric cells in the CD4+ T cell population in peripheral blood. CD4+ T cells are important effector molecules in mediating GVHD. This article adds support to the hypothesis that SSc may be a GVHD mediated disease.CrossRefPubMedGoogle Scholar
- 4.Nelson JL, Furst DE, Maloney S, et al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559–562. This publication confirms the Artlett et al.  study by demonstrating HLA compatibility in SSc families; it also demonstrates microchimeric cells in the peripheral blood of women with SSc.CrossRefPubMedGoogle Scholar
- 8.Zhang Y, McCormick LL, Desai SR, et al.: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088–3098. This article investigates and demonstrates the importance of the murine sclerodermatous GVHD as a model for SSc.PubMedGoogle Scholar
- 11.Artlett CM, Sawaya HHB, Russo-Stieglitz KE, et al.: Persistent microchimerism is not associated with HLA-DQA1 in systemic sclerosis or juvenile myositis [manuscript submitted for publication]. Journal 2003, In press.Google Scholar
- 23.Martin WL, Durrant LG, Liu DTY: Non-invasive fetal cell isolation from maternal blood. Br J Obstet Gynecol 1998, 105:576–583.Google Scholar
- 24.Cox LA, Ramos RC, Dennis TN, et al.: Detection of microchimeric cells in the peripheral blood of non-pregnant women is enhanced by magnetic cell sorting prior to PCR. Arthritis Rheum 2003, In press.Google Scholar
- 25.Ohtsuka T, Miyamoto Y, Yamakage A, Yamazaki S: Quantitative analysis of microchimerism in systemic sclerosis tissue. Arch Dermatol Res 2001, 293:387–391. This article reports that SSc lesions have increased numbers of fetal microchimeric cells compared with other autoimmune diseases and control individuals.CrossRefPubMedGoogle Scholar
- 26.Scaletti C, Vultaggio A, Bonifacio S, et al.: TH2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002, 46:445–450. This paper was the first to demonstrate that male fetal cells actively recognize the HLA alleles from patients with SSc, use mixed lymphocyte reactiona, and that these cells produce an abundance of interleukin-4.CrossRefPubMedGoogle Scholar
- 27.Artlett CM, Sawaya HHB, Johnson-Hopson CN, et al.: Microchimeric cells identified by immunophenotyping and fluorescence in situ hybridization in active lesions from patients with systemic sclerosis are activated T cells. Arthritis Rheum 2003, In press. This abstract investigates the phenotypes of the microchimeric cells in the active lesions of patients with SSc and that these cells are activated T cells.Google Scholar
- 35.Aractingi S, Sibilia J, Meignin V, et al.: Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjogren’s syndrome. Arthritis Rheum 2002, 46:1039–1043. Identification of microchimeric cells in the salivary glands of patients with SSc, but not in patients with Sjögren’s syndrome.CrossRefPubMedGoogle Scholar